Sagar Lonial

26PUBLICATIONS
166CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycologyGene and molecular therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Dec 09, 2025
Longitudinal Profiling of Tumor and Immune Compartments Uncovers Patterns of Dysregulation and Associations with Response in Multiple Myeloma.

Denis J Ohlstrom, William C Pilcher, Marina E Michaud

|Dec 04, 2025
Final OS analyses from the TOURMALINE- MM3 and -MM4 RCTs of ixazomib maintenance in newly diagnosed multiple myeloma.

Meletios A Dimopoulos, Sagar Lonial, Wee-Joo Chng

|May 10, 2025
EXCALIBER-RRMM: a phase III trial of iberdomide, daratumumab, and dexamethasone in relapsed/refractory multiple myeloma.

Sagar Lonial, Meletios A Dimopoulos, Jesus G Berdeja

|Feb 07, 2025
The clinical journey of belantamab mafodotin in relapsed or refractory multiple myeloma: lessons in drug development.

Pralay Mukhopadhyay, Hesham A Abdullah, Joanna B Opalinska

|Dec 05, 2024
Real-world characteristics and outcomes of patients with high-risk and non-high-risk smoldering multiple myeloma using the Flatiron Health database.

S Vincent Rajkumar, María-Victoria Mateos, Marcy Schaeffer

|Sep 13, 2024
Quadruplet therapy for newly diagnosed myeloma: comparative analysis of sequential cohorts with triplet therapy lenalidomide, bortezomib and dexamethasone (RVd) versus daratumamab with RVD (DRVd) in transplant-eligible patients.

Nisha S Joseph, Jonathan L Kaufman, Vilas A Gupta

Pageof 5

Frequent Collaborators

11 joint publications

Ajay Nooka

7 joint publications

Madhav V Dhodapkar

6 joint publications

Jonathan L Kaufman

6 joint publications

Maria-Victoria Mateos